The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

Copia Wealth Studios today announced the launch of "Copia - Clarity," an advanced wealth management platform designed specifically for sophisticated allocators managing diverse investment portfolios.

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

Star Equity Holdings, Inc. is a diversified holding company with three divisions: Building Solutions, Energy Services, and ...

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment, leveraging its CD123-targeted efficacy per 0114 trial ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and challenging disease.

Researchers have uncovered critical mechanisms linked to metabolic insufficiencies that underlie plasmacytoid dendritic cell ...

Zúñiga believes that interventions that target LDHB or related metabolic pathways could be explored as a way to counteract ...

In one study, a team of researchers led by Franck Barrat, Ph.D., found that two genetic receptors called TLR7 and TLR8, which are present on the X chromosome, are important drivers for the activation ...

are important drivers for the activation of plasmacytoid dendritic cells (pDCs), fueling chronic fibrosis. pDCs are immune cells found in fibrotic skin but not in healthy skin and have previously ...